Aller au contenu principal
Profil bibliographique

Elizaveta Lukashova

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

1Publications signalées
0Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Cardiac Ischemia and ReperfusionChemotherapy-induced cardiotoxicity and mitigationCancer Treatment and Pharmacology

Les publications récentes

2026 conference-abstract OpenAlex

Clinical factors associated with durable response to atezolizumab in extensive-stage small-cell lung cancer: A real-world analysis in Moscow.

Evgenia Khatkova, Demid Shchetinkin, Elizaveta Lukashova, Сергей Смолин et autres

e20160 Background: Atezolizumab (A) in combination with platinum-etoposide chemotherapy represents the current standard of care for the first-line treatment of extensive-stage small-cell lung cancer (ES-SCLC). However, sustained clinical benefit is achieved only in a limited cohort of patients (pts). Identifying predictors of …

ru (code pays fourni par la source)

0 citations Journal of Clinical Oncology
2026 conference-abstract OpenAlex

Efficacy of primary cardioprotection with perindopril, bisoprolol, and trimetazidine in high-risk patients with breast and gastric cancer receiving anthracycline- and trastuzumab-containing therapy.

Evgenia Khatkova, Evgenia Novosel, Elizaveta Lukashova, Elena Stauver et autres

12028 Background: Anthracyclines and trastuzumab are the most common antitumor agents associated with a substantial risk of cardiotoxicity (CTX). Patients with high or very high cardiovascular risk represent a vulnerable population where even subclinical myocardial injury can translate into clinically significant cardiac …

ru (code pays fourni par la source)

0 citations Journal of Clinical Oncology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.